Antibody Cocktail Offers Long-Lasting COVID-19 Protection
A new announcement from Regeneron Pharmaceuticals could be good news for the immunocompromised.
A new announcement from Regeneron Pharmaceuticals could be good news for the immunocompromised.
The vaccine would be easy to store and transport, even in remote corners of the globe, and could be manufactured in bulk using existing vaccine factories. Plus it could cost only about $1 a dose.
Our Bill Petri Jr., MD, PhD, has answers.
The findings underscore the need for vaccination in the battle against COVID-19.
The maker of an antibody cocktail announced that it was able to prevent 100% of symptomatic infections and reduced overall infections (both symptomatic and asymptomatic) by half.
At-risk people diagnosed with COVID-19 across the United States and Canada can participate in the testing of a common antidepressant.